InSite obtains rights to optineurin gene

A test for the optineurin gene will be available to ophthalmologists soon - possibly this year and certainly by 2003, said S. Kumar Chandrasekaran, PhD, CEO of InSite Vision, Alameda, CA.

Related Content

---

Tamsulosin-intraoperative floppy iris syndrome link is urged to be considered by primary care physicians

Article

---

Anticipate silodosin-IFIS link, surgeon says

Article

---

ASCRS, AAO have new advice for primary care physicians about alpha blockers and IFIS

Article

---

Techniques can help surgeons manage IFIS

Article

---

Medications for ED can harm optic nerve

Article

---

Alternative strategies successful in managing IFIS

Article